CTIS2024-512642-42-00招募中1 期
Randomized study to protect from radiation iatrogenic hypothyroidism patients with medulloblastoma (any stage, any biological risk) and pediatric patients with Hodgkin lymphoma and non-Hodgkin lymphoma needing radiation therapy on thyroid site - WINHYPO 2021
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 65
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 65+（—）
- 性别
- All
入选标准
- •Any patient with medulloblastoma, Hodgkin/non-Hodgkin Lymphoma BEFORE RADIOTHERAPY (RT) PLANNING INCLUDING THYROID PARENCHYMA without previous primary or secondary hypothyroidism;, Written informed consent prior to any study-specific analysis and/or data collection.
排除标准
- •Any patient with medulloblastoma, Hodgkin/non-Hodgkin Lymphoma after radiotherapy including thyroid parenchyma;, Not signed consent.
研究者
相似试验
进行中（未招募）
1 期
RANDOMIZED STUDY TO PROTECT FROM RADIATION IATROGENIC HYPOTHYROIDISM PATIENTS WITH MEDULLOBLASTOMA (ANY AGE, STAGE AND ANY BIOLOGICAL RISK) AND PEDIATRIC PATIENTS WITH HODGKIN LYMPHOMA AND NON-HODGKIN LYMPHOMA NEEDING RADIATION THERAPY ON THYROID SITEEUCTR2021-001385-38-ITFONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI51
招募中
不适用
Radiation Protection Effects of Metformin in Prostate CancerProstate cancer.Malignant neoplasm of prostateIRCT20170307032933N3Ahvaz University of Medical Sciences60
尚未招募
不适用
In this study the Sun Protection Factor of SPF will be determined.CTRI/2019/01/017283Sami Labs Limited
已完成
不适用
A study to check the sun protection benefitsCTRI/2023/02/049856nilever Industries Pvt Ltd10
已完成
2 期
A study to determine the protection factor of a test product against sun rays.CTRI/2021/04/032696ITC Life Sciences Technology Centre20